Susquehanna International Group, LLP Bioventus Inc. Transaction History
Susquehanna International Group, LLP
- $568 Billion
- Q1 2025
A detailed history of Susquehanna International Group, LLP transactions in Bioventus Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 55,259 shares of BVS stock, worth $359,183. This represents 0.0% of its overall portfolio holdings.
Number of Shares
55,259
Previous 27,292
102.47%
Holding current value
$359,183
Previous $286,000
76.57%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding BVS
# of Institutions
153Shares Held
47.7MCall Options Held
77.9KPut Options Held
39.3K-
Essex Woodlands Management, Inc. The Woodlands, TX13MShares$84.6 Million34.4% of portfolio
-
Juniper Investment Company, LLC New York, NY6.94MShares$45.1 Million27.92% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT4.13MShares$26.8 Million1.7% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.55MShares$16.6 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.37MShares$15.4 Million0.0% of portfolio
About Bioventus Inc.
- Ticker BVS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 61,664,200
- Market Cap $401M
- Description
- Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral ner...